Interleukin-30 (IL27p28) alleviates experimental sepsis by modulating cytokine profile in NKT cells

Journal of Hepatology

Volumn 64, Issue 5, 2016, Pages 1128-1136

  Yan, Jun ^a   Mitra, Abhisek ^a   Hu, Jiemiao ^a   Cutrera, Jeffery J ^a   Xia, Xueqing ^a   Doetschman, Thomas ^b   Gagea, Mihai ^a   Mishra, Lopa ^a   Li, Shulin ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BIO5 Institute   (United States)

Author keywords

Gp130.; IL 10; IL 6R; Liver injury; Natural killer T cells; NF rB

Indexed keywords

ANTIINFLAMMATORY AGENT; GAMMA INTERFERON; GLYCOPROTEIN GP 130; INTERLEUKIN 10; INTERLEUKIN 6 RECEPTOR; LIPOPOLYSACCHARIDE; RECOMBINANT CYTOKINE; RECOMBINANT INTERLEUKIN 30; STAT1 PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; IL27 PROTEIN, MOUSE; INTERLEUKIN DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; BACTERIAL CLEARANCE; CECAL LIGATION AND PUNCTURE-INDUCED SEPSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; EXPERIMENTAL SEPTIC SHOCK; GENE THERAPY; HEPATITIS; IMMUNOREGULATION; LIPOPOLYSACCHARIDE-INDUCED SEPSIS; LIVER CELL; LIVER INJURY; LIVER PROTECTION; MALE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; SPLEEN CELL; ANIMAL; C3H MOUSE; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; FLOW CYTOMETRY; IMMUNOLOGY; LIVER; METABOLISM; PATHOLOGY; SHOCK, SEPTIC;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; INTERLEUKINS; LIVER; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; NATURAL KILLER T-CELLS; SHOCK, SEPTIC;

EID: 84959182743     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.12.020     Document Type: Article

References (30)

1. J.S. Stumhofer, E.D. Tait, W.J. Quinn III, N. Hosken, B. Spudy, R. Goenka, and et al. A role for IL-27p28 as an antagonist of gp130-mediated signaling Nat Immunol 11 2010 1119 1126
2. D. Dibra, J. Cutrera, X. Xia, B. Kallakury, L. Mishra, and S. Li Interleukin-30: a novel antiinflammatory cytokine candidate for prevention and treatment of inflammatory cytokine-induced liver injury Hepatology 55 2012 1204 1214
3. S. Zhang, R. Liang, W. Luo, C. Liu, X. Wu, Y. Gao, and et al. High susceptibility to liver injury in IL-27 p28 conditional knockout mice involves intrinsic interferon-gamma dysregulation of CD4+ T cells Hepatology 57 2013 1620 1631
4. A. Mitra, A. Satelli, J. Yan, X. Xueqing, M. Gagea, C.A. Hunter, and et al. IL-30 (IL27p28) attenuates liver fibrosis through inducing NKG2D-rae1 interaction between NKT and activated hepatic stellate cells in mice Hepatology 60 2014 2027 2039
5. W.P. Chong, R. Horai, M.J. Mattapallil, P.B. Silver, J. Chen, R. Zhou, and et al. IL-27p28 inhibits central nervous system autoimmunity by concurrently antagonizing Th1 and Th17 responses J Autoimmun 50 2014 12 22
6. R.S. Hotchkiss, and D.W. Nicholson Apoptosis and caspases regulate death and inflammation in sepsis Nat Rev Immunol 6 2006 813 822
7. P.A. Danai, M. Moss, D.M. Mannino, and G.S. Martin The epidemiology of sepsis in patients with malignancy Chest 129 2006 1432 1440
8. W. Schulte, J. Bernhagen, and R. Bucala Cytokines in sepsis: potent immunoregulators and potential therapeutic targets-an updated view Mediat Inflamm 2013 2013 165974
9. S. Wirtz, I. Tubbe, P.R. Galle, H.J. Schild, M. Birkenbach, R.S. Blumberg, and et al. Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27 J Exp Med 203 2006 1875 1881
10. H.R. Wong, N.Z. Cvijanovich, M. Hall, G.L. Allen, N.J. Thomas, R.J. Freishtat, and et al. Interleukin-27 is a novel candidate diagnostic biomarker for bacterial infection in critically ill children Crit Care 16 2012 R213
11. J.C. Alves-Filho, F. Sonego, F.O. Souto, A. Freitas, W.A. Verri Jr., M. Auxiliadora-Martins, and et al. Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection Nat Med 16 2010 708 712
12. D. Rittirsch, M.S. Huber-Lang, M.A. Flierl, and P.A. Ward Immunodesign of experimental sepsis by cecal ligation and puncture Nat Protoc 4 2009 31 36
13. Z.X. Liu, S. Govindarajan, S. Okamoto, and G. Dennert NK cells cause liver injury and facilitate the induction of T cell-mediated immunity to a viral liver infection J Immunol 164 2000 6480 6486
14. J. Yan, L.Y. Kong, J. Hu, K. Gabrusiewicz, D. Dibra, X. Xia, and et al. FGL2 as a multimodality regulator of tumor-mediated immune suppression and therapeutic target in gliomas J Natl Cancer Inst 107 2015
15. Y.C. Lu, W.C. Yeh, and P.S. Ohashi LPS/TLR4 signal transduction pathway Cytokine 42 2008 145 151
16. T.K. Varma, C.Y. Lin, T.E. Toliver-Kinsky, and E.R. Sherwood Endotoxin-induced gamma interferon production: contributing cell types and key regulatory factors Clin Diagn Lab Immunol 9 2002 530 543
17. B. Leung, and H.W. Harris NKT Cells: The Culprits of Sepsis? J Surg Res 167 2011 87 95
18. N.A. Nagarajan, and M. Kronenberg Invariant NKT cells amplify the innate immune response to lipopolysaccharide J Immunol 178 2007 2706 2713
19. C.K. Hu, F. Venet, D.S. Heffernan, Y.L. Wang, B. Horner, X. Huang, and et al. The role of hepatic invariant NKT cells in systemic/local inflammation and mortality during polymicrobial septic shock J Immunol 182 2009 2467 2475
20. H. Yoshida, and C.A. Hunter The immunobiology of interleukin-27 Annu Rev Immunol 33 2015 417 443
21. A. Laroni, R. Gandhi, V. Beynon, and H.L. Weiner IL-27 imparts immunoregulatory function to human NK cell subsets PLoS One 6 2011 e26173
22. D. Dibra, and S. Li The cell-to-cell coordination between activated T cells and CpG-stimulated macrophages synergistically induce elevated levels of IL-10 via NF-kappaB1, STAT3, and CD40/CD154 Cell Commun Signal 11 2013 95
23. D. Sag, P. Krause, C.C. Hedrick, M. Kronenberg, and G. Wingender IL-10-producing NKT10 cells are a distinct regulatory invariant NKT cell subset J Clin Invest 124 2014 3725 3740
24. C. Garbers, B. Spudy, S. Aparicio-Siegmund, G.H. Waetzig, J. Sommer, C. Holscher, and et al. An interleukin-6 receptor-dependent molecular switch mediates signal transduction of the IL-27 cytokine subunit p28 (IL-30) via a gp130 protein receptor homodimer J Biol Chem 288 2013 4346 4354
25. A. Villarino, L. Hibbert, L. Lieberman, E. Wilson, T. Mak, H. Yoshida, and et al. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection Immunity 19 2003 645 655
26. R.X. Wang, C.R. Yu, R.M. Mahdi, and C.E. Egwuagu Novel IL27p28/IL12p40 cytokine suppressed experimental autoimmune uveitis by inhibiting autoreactive Th1/Th17 cells and promoting expansion of regulatory T cells J Biol Chem 287 2012 36012 36021
27. S. Crabe, A. Guay-Giroux, A.J. Tormo, D. Duluc, R. Lissilaa, F. Guilhot, and et al. The IL-27 p28 subunit binds cytokine-like factor 1 to form a cytokine regulating NK and T cell activities requiring IL-6R for signaling J Immunol 183 2009 7692 7702
28. G.P. Dobson Addressing the global burden of sepsis: importance of a systems-based approach Crit Care Med 42 2014 e797 e798
29. M.F. Nold, C.A. Nold-Petry, J.A. Zepp, B.E. Palmer, P. Bufler, and C.A. Dinarello IL-37 is a fundamental inhibitor of innate immunity Nat Immunol 11 2010 1014 1022
30. R.S. Hotchkiss, and S. Opal Immunotherapy for sepsis - A new approach against an ancient foe N Engl J Med 363 2010 87 89